Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,085 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis.
You R, Cao YS, Huang PY, Chen L, Yang Q, Liu YP, Zou X, Zhang YN, Jiang R, Zhang MX, Duan CY, Lin AH, Hong MH, Chen MY. You R, et al. Among authors: zhang yn, zhang mx. Theranostics. 2017 Oct 17;7(19):4825-4835. doi: 10.7150/thno.21815. eCollection 2017. Theranostics. 2017. PMID: 29187906 Free PMC article.
Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma.
You R, Sun R, Hua YJ, Li CF, Li JB, Zou X, Yang Q, Liu YP, Zhang YN, Yu T, Cao JY, Zhang MX, Jiang R, Mo HY, Guo L, Cao KJ, Lin AH, Qian CN, Sun Y, Ma J, Chen MY. You R, et al. Among authors: zhang yn, zhang mx. Int J Cancer. 2017 Sep 15;141(6):1265-1276. doi: 10.1002/ijc.30819. Epub 2017 Jun 23. Int J Cancer. 2017. PMID: 28577306
Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up.
You R, Hua YJ, Liu YP, Yang Q, Zhang YN, Li JB, Li CF, Zou X, Yu T, Cao JY, Zhang MX, Jiang R, Sun R, Mo HY, Guo L, Cao KJ, Lin AH, Sun Y, Qian CN, Ma J, Chen MY. You R, et al. Among authors: zhang yn, zhang mx. Theranostics. 2017 Jun 1;7(8):2314-2324. doi: 10.7150/thno.19710. eCollection 2017. Theranostics. 2017. PMID: 28740554 Free PMC article.
A Prognostic Bio-Model Based on SQSTM1 and N-Stage Identifies Nasopharyngeal Carcinoma Patients at High Risk of Metastasis for Additional Induction Chemotherapy.
Yang Q, Zhang MX, Zou X, Liu YP, You R, Yu T, Jiang R, Zhang YN, Cao JY, Hong MH, Liu Q, Guo L, Kang TB, Zhu XF, Chen MY. Yang Q, et al. Among authors: zhang yn, zhang mx. Clin Cancer Res. 2018 Feb 1;24(3):648-658. doi: 10.1158/1078-0432.CCR-17-1963. Epub 2017 Oct 13. Clin Cancer Res. 2018. PMID: 29030355
Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma.
Lin M, You R, Liu YP, Zhang YN, Zhang HJ, Zou X, Yang Q, Li CF, Hua YJ, Yu T, Cao JY, Li JB, Mo HY, Guo L, Lin AH, Sun Y, Qian CN, Ma J, Mai HQ, Chen MY. Lin M, et al. Among authors: zhang yn, zhang hj. Oral Oncol. 2018 May;80:1-8. doi: 10.1016/j.oraloncology.2018.03.002. Epub 2018 Mar 13. Oral Oncol. 2018. PMID: 29706183
Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: Selective or comprehensive neck dissection.
Liu YP, Li H, You R, Li JB, Liu XK, Yang AK, Guo X, Song M, Zhang Q, Guo ZM, Chen WK, Liu WW, Zou X, Hua YJ, Yang Q, Zhang YN, Sun R, Mo HY, Guo L, Lin AH, Mai HQ, Qian CN, Chen MY. Liu YP, et al. Among authors: zhang yn, zhang q. Laryngoscope. 2019 Feb;129(2):387-395. doi: 10.1002/lary.27317. Epub 2018 Oct 16. Laryngoscope. 2019. PMID: 30325027
A curative-intent endoscopic surgery for postradiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma.
Zou X, Wang SL, Liu YP, Liu YL, Zou RH, Zhang YN, You R, Yang Q, Xie YL, Lin M, Huang PY, Jiang R, Zhang MX, Qian CN, Mai HQ, Guo L, Hong MH, Chen MY. Zou X, et al. Among authors: zhang yn, zhang mx. Cancer Commun (Lond). 2018 Dec 22;38(1):74. doi: 10.1186/s40880-018-0338-4. Cancer Commun (Lond). 2018. PMID: 30577735 Free PMC article.
Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients.
You R, Liu YP, Lin M, Huang PY, Tang LQ, Zhang YN, Pan Y, Liu WL, Guo WB, Zou X, Zhao KM, Kang T, Liu LZ, Lin AH, Hong MH, Mai HQ, Zeng MS, Chen MY. You R, et al. Among authors: zhang yn. Int J Cancer. 2019 Nov 15;145(10):2873-2883. doi: 10.1002/ijc.32380. Epub 2019 Jun 10. Int J Cancer. 2019. PMID: 31044420
Clonal Mutations Activate the NF-κB Pathway to Promote Recurrence of Nasopharyngeal Carcinoma.
You R, Liu YP, Lin DC, Li Q, Yu T, Zou X, Lin M, Zhang XL, He GP, Yang Q, Zhang YN, Xie YL, Jiang R, Wu CY, Zhang C, Cui C, Wang JQ, Wang Y, Zhuang AH, Guo GF, Hua YJ, Sun R, Yun JP, Zuo ZX, Liu ZX, Zhu XF, Kang TB, Qian CN, Mai HQ, Sun Y, Zeng MS, Feng L, Zeng YX, Chen MY. You R, et al. Among authors: zhang xl, zhang yn, zhang c. Cancer Res. 2019 Dec 1;79(23):5930-5943. doi: 10.1158/0008-5472.CAN-18-3845. Epub 2019 Sep 4. Cancer Res. 2019. PMID: 31484669
1,085 results